Ali Hasbini
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 21
- Prostate Cancer Diagnosis and Treatment 14
- Renal cell carcinoma treatment 2
-
- Head and Neck Cancer Studies 9
- Co-authors
- Esteban Cvitkovic (4 shared papers)Jean‐Pierre Armand (4 shared papers)Nadia Chouaki (2 shared papers)Pascal Pommier (6 shared papers)Abdelkrim Taamma (2 shared papers)Stéphane Supiot (13 shared papers)I. Latorzeff (10 shared papers)G. Créhange (6 shared papers)
In The Last Decade
Ali Hasbini
51 papers receiving 2.5k citations
Ali Hasbini's Hit Papers
Peers
Comparison fields: 5 of 72
- Otorhinolaryngology 385
- Pulmonary and Respiratory Medicine 1.8k
- Radiation 89
- Oncology 164
- Cancer Research 64
Countries citing papers authored by Ali Hasbini
This map shows the geographic impact of Ali Hasbini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Hasbini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Hasbini more than expected).
Fields of papers citing papers by Ali Hasbini
This network shows the impact of papers produced by Ali Hasbini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Hasbini. The network helps show where Ali Hasbini may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Hasbini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2013 | 575 |
| 2 | Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design Hit paper breakdown → | 2022 | 560 |
| 3 | 2016 | 275 | |
| 4 | Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial Hit paper breakdown → | 2021 | 157 |
| 5 | 2018 | 114 | |
| 6 | 2014 | 102 | |
| 7 | 2021 | 69 | |
| 8 | 2018 | 65 | |
| 9 | 2014 | 55 | |
| 10 | 2017 | 53 | |
| 11 | 1999 | 50 | |
| 12 | 1999 | 49 | |
| 13 | 2023 | 48 | |
| 14 | 2024 | 44 | |
| 15 | 2021 | 36 | |
| 16 | 2002 | 32 | |
| 17 | 2018 | 32 | |
| 18 | 2018 | 25 | |
| 19 | 2008 | 17 | |
| 20 | 2009 | 13 |
About Ali Hasbini
Ali Hasbini is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology, Radiation, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 54 papers that have together received 2.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (21 papers), Prostate Cancer Diagnosis and Treatment (14 papers), Head and Neck Cancer Studies (9 papers), Advances in Oncology and Radiotherapy (2 papers), Advanced Radiotherapy Techniques (2 papers), Cancer survivorship and care (2 papers), Breast Cancer Treatment Studies (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Otorhinolaryngology (385 citations), Pulmonary and Respiratory Medicine (1.8k citations), Radiation (89 citations), Oncology (164 citations) and Cancer Research (64 citations). Ali Hasbini has collaborated with scholars based in France, Italy and Spain. Frequent co-authors include Esteban Cvitkovic, Jean‐Pierre Armand, Nadia Chouaki, Pascal Pommier, Abdelkrim Taamma, Stéphane Supiot, I. Latorzeff, G. Créhange, Paul Sargos and Dominique Pasquier. Their work appears in journals such as Annals of Oncology, European Urology, The Lancet Oncology, Radiotherapy and Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.